Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes.
The influence of the isolation procedure of hepatocytes, extracellular matrix (ECM) configuration and incubation medium supplementation by dexamethasone (DEX) on the cell morphology and on the gene expression of membrane transporters was examined in rat hepatocytes. The mRNA levels were determined using oligonucleotide microarrays, in liver, in suspension and in primary culture in monolayer (CPC), and in collagen gels sandwich (SPC) in absence and presence of DEX (100 and 1000 nM). The results indicated pronounced morphological differences between CPC and SPC in response to DEX demonstrating that the hepatocytes re-formed, as in vivo, multicellular arrays with extensive bile canalicular network only in SPC in presence of DEX. The mRNA levels of membrane transporters were not affected significantly during isolation procedure. However, plating hepatocytes in CPC resulted in a decrease of major basolateral transporters mRNA level whereas mRNA levels of mdr1b and mrp3 were increased (>100-fold). Similar observations were made in SPC in the absence of DEX demonstrating that the ECM configuration alone did not play a critical role in the regulation of membrane transporters. However, adding DEX to the incubation medium in SPC resulted in an up-regulation of mdr2, oatp2 and mrp2 in a concentration-dependent way for the two latter genes, whereas mdr1b and mrp3 expression were maintained to their baseline liver levels. These data suggested therefore that the combination of ECM and DEX supplementation is essential for the formation of the bile canalicular network and is a determinant factor in the regulation of membrane transporters in cultured rat hepatocytes.
Luttringer
Olivier
O
F. Hoffmann-La Roche Ltd., Pharmaceutics, CH-4070, Basel, Switzerland. olivier.luttringer@roche.com
Theil
Frank Peter
FP
Lavé
Thierry
T
Wernli-Kuratli
Karin
K
Guentert
Theodor W
TW
de Saizieu
Antoine
A
D018435:ATP Binding Cassette Transporter, Subfamily B / Q000096:biosynthesis; D018528:ATP-Binding Cassette Transporters / Q000096:biosynthesis; D000818:Animals; D048429:Cell Size / Q000187:drug effects; D002478:Cells, Cultured; D019742:Chemokines, CC / Q000096:biosynthesis; D003907:Dexamethasone / Q000494:pharmacology*; D005109:Extracellular Matrix / Q000187:drug effects*; D005786:Gene Expression Regulation / Q000187:drug effects*; D022781:Hepatocytes / Q000187:drug effects* / Q000502:physiology; D019402:Macrophage Inflammatory Proteins / Q000096:biosynthesis; D026901:Membrane Transport Proteins / Q000096:biosynthesis / Q000235:genetics*; D051381:Rats
D018435:ATP Binding Cassette Transporter, Subfamily B; D018528:ATP-Binding Cassette Transporters; C095218:Ccl9 protein, mouse; D019742:Chemokines, CC; D019402:Macrophage Inflammatory Proteins; D026901:Membrane Transport Proteins; C070959:Ccl6 protein, mouse; D003907:Dexamethasone; C095122:multidrug resistance protein 3